Explore
Communities in English
Advertise on Engormix

Modulating Laying Hens Productivity and Immune Performance in Response to Oxidative Stress Induced by E. coli Challenge Using Dietary Propolis Supplementation

Published: March 19, 2021
By: Ahmed O. Abbas 1,2; Abdulaziz A. Alaqil 1; Hossam S. El-Beltagi 3,4; Hanaa K. Abd El-Atty 5 and Nancy N. Kamel 6.
Summary
Author details:

1 Department of Animal and Fish Production, College of Agricultural and Food Sciences, King Faisal University, P.O. Box 420, Al-Ahsa 31982, Saudi Arabia; 2 Department of Animal Production, Faculty of Agriculture, Cairo University, Gamma St., Giza, Cairo P.O. Box 12613, Egypt; 3 Department of Agricultural Biotechnology, College of Agricultural and Food Sciences, King Faisal University, P.O. Box 420, Al-Ahsa 31982, Saudi Arabia; 4 Department of Biochemistry, Faculty of Agriculture Cairo University, Gamma St., Giza, Cairo P.O. Box 12613, Egypt; 5 Department of Poultry Breeding, Animal Production Research Institute, Agricultural Research Center, Dokki, Giza P.O. Box 12611, Egypt; 6 Department of Animal Production, National Research Center, El Buhouth St., Dokki, Giza, Cairo P.O. Box 12622, Egypt.

Propolis (PR) is a resin product of bee colonies that has rich bioactive antioxidant and bactericidal compounds. Endotoxin, a byproduct of bacterial growth, is reported to cause progressive induction of endogenous oxidative stress and has negative impacts on individual health and wellbeing. Hereby, we investigated the ability of PR to alleviate the oxidative stress and immunosuppression imposed by avian pathogenic Escherichia coli using laying hen as a based model. In this study, PR was dietary supplemented to hens for 4 weeks at a concentration of 0.1%. At the beginning of the 4th week of the experiment, hens from control and PR treatment were injected with E. coli (O157:H7; 107 colonies/hen) or saline. The results showed significant (p < 0.05) negative impact of E. coli challenge on antioxidant status, immune response and productive performance. PR supplementation reduced (p < 0.05) inflammation markers levels (tumor necrosis factor α (TNFα) and interleukin 1β (IL-1β)) and plasma corticosterone concentration. The antioxidant status was ameliorated with dietary PR supplementation to challenged hens, showing significant (p < 0.05) reduction in malondialdehyde (MDA) levels and increasing total antioxidant capacity (TAC) concentrations. Cell mediated, as well as, humeral immune response improved significantly (p < 0.05) with dietary PR verified by the enhancement of T- and B-lymphocyte proliferation and the positive respond to phytohemagglutinin (PHA). Leucocyte cells viability increased significantly and the apoptotic factor forkhead box O3 (Foxo3) was reduced with PR supplementation. The current study revealed that dietary PR supplementation can effectively be used as an organic feed additive to overcome the endogenous oxidative stress induced by endotoxins challenge.

Keywords: propolis; E. coli; inflammation markers; lymphocyte proliferation; leucocyte cell viability; Foxo3; laying hen.


1. Introduction
Recently, oxidative stress has become a major concern as a life threatening and a chronic-disease mediator [1–3]. The reactive oxygen or nitrogen species (ROS, RNS) are normally generated during the respiratory chain reaction in the mitochondria. Nevertheless, the excessive production of such ROS and RNS induces oxidative stress, homeostasis imbalance and subsequent pathological conditions [4]. Bacterial infection activates immune cells and induces inflammation, which is considered as being responsible for endogenous free radical production [5]. T helper cell (Th1) mediates the immune system protection to specific pathogens by the secretion of different pro-inflammatory cytokines such as interferon gamma (IFN-γ), interleukin-2 (IL-2), tumor necrosis factor α (TNF-α), lymphotoxin and granulocyte-macrophage colony-stimulating factor [6]. The excessive pro-inflammatory cytokines release and the excess formation of ROS/RNS induce uncontrolled tissue damage. Thus, in order to alleviate the negative impact of bacterial infection and the oxidative-load imposed under such conditions, antioxidant and antimicrobial agents are required. However, multidrug-resistance pathogens have become an increasing national and international concern [7–9]. Food-borne diseases and antibiotic-resistance bacteria impose increasing hazards on human health [10,11]. Pollution due to the presence of antibiotic residues contributed to the increasing occurrence of multidrug-resistance microbes and increased abundance of antibiotic-resistance genes [12,13].
Escherichia coli (E. coli) is a Gram negative, facultative anaerobic bacterium that naturally lives not only in chicken and human guts but also in other warm-blooded animals. E. coli is considered to be the primary bacterial species that leads to the spreading of antibiotic-resistance gene in poultry farms [14]. Infection with avian pathogenic E. coli strains (APEC) negatively affected both humeral and cellular immune responses of broiler chickens [15]. Moreover, oral administration of E. coli caused an increase in gut-pathogenic bacterial counts and a reduction in beneficial bacterial counts [16]. Furthermore, in Egypt, Ramadan et al. [17] demonstrated the existence of shared antimicrobial resistances between E. coli isolated from retail chicken carcasses and humans. Recently, there has been an increasing interest in replacing antibiotics with an alternative variety of natural products, such as medicinal plants [15,18] and probiotics [18–21], to ameliorate poultry antioxidant status, immune response, growth performance and egg production.
Propolis (PR) is a resinous material produced by honeybees (Apis mellifera) from beeswax and resins collected from plants. Honeybees use PR as a social immune defense against different kinds of parasites and pathogens [22]. The presence of antimicrobial, antioxidant and cytotoxic phytochemicals in PR ethanol extract were reported [23]. Polyphenols and flavonoids are major PR compounds that were found to be related to their antioxidant effect in a dose-dependent manner [24–26]. PR extraction and its derivative reported to have antioxidant [27], antimicrobial [28], anti-inflammatory [29,30] and cytotoxic [30] activities. In poultry, PR has been recently used for its antioxidant, antimicrobial and growth promoting ability [31–35]. However, the interactions among in vivo antioxidant, antimicrobial, anti-inflammation and immune-modulation effects of PR specially regulating cell death program of immune cells and T and B lymphocyte proliferation under endotoxin stress have not been fully investigated. Thus, the present study was designed to evaluate the phyto-therapeutic ability of PR to overcome the negative effects of endotoxins after E. coli challenge and its subsequent induction of oxidative load on laying hen. Oxidative status, immune response, gut morphology and productive performance were the main studied aspects.
2. Materials and Methods
2.1. Birds and Ethical Statement
After E. coli challenge, scheduled observations were set for evaluating the pathogenic stress symptoms progression on the wellbeing of the experimental birds. Challenged hens were closely monitored to detect any signs of distress (i.e., decreased appetite, listless, ruffled feathers, beak fluid discharge, breathing difficulty or fever). Consequently, to minimize bird suffering, if at least one of the above-mentioned signs appeared the body temperature was immediately taken. If the temperature elevated to be 43.5 °C or higher, cervical dislocation was used to allow a humane endpoints. Ethical approval, for all the practiced experimental protocols, was obtained from Medical Research Ethics Committee, National Research Center (NRC-MREC; number, 20/129) according to Egyptian Network of Research Ethics Committee (ENREC) regulations.
2.2. Experimental Design and Birds Management
A total of 240 healthy H&N Brown Nick layer chickens at 40-weeks of age were recruited and randomly assigned into two equal dietary treatments. The dietary treatments lasted for four weeks, where the control groups received a basal diet, while the propolis-supplementation groups received the basal diet supplemented with 0.1% propolis (1 g/kg diet). At the beginning of the 4th week of the experiment, hens from the control and propolis supplementation groups were further divided into two sub-groups each (5 replicates, 12 hens each). One of each sub-group was challenged with single intraperitoneal (ip) injection of E. coli O157:H7 (107 colonies/hen dissolved in 0.5 mL of sterile saline), while the remaining two sub-groups were ip injected with 0.5 mL sterile saline. Consequently, the experimental groups were assigned as follow; (1) control with saline injection (C); (2) control with E. coli challenge (EC); (3) propolis supplementation with E. coli challenge, (PR + EC) and (4) propolis supplementation with saline injection (PR)
The basal diet was prepared to meet the nutrition requirements of hens under the new management guide of H&N® International (https://www.hn-int.com/). Diet and fresh water were offered ad libitum. Hens were housed in laying cages with 3 hens per cage in an open poultry house. The light regimen was set to be 16L:8D throughout the experimental period. The E. coli used in this study was brought from the U.S. Department of Health and Human Services (Washington D.C., USA) through Cairo Microbiological Resources Center (Cairo, Egypt). PR was purchased, in a powder form, from the apiary of the Faculty of Agriculture Cairo University, located in Giza governorate, Egypt. PR was collected during March 2020, and was stored in dark sealed glass bottle until its use.
2.3. Blood Sample Collection and Preparation
At the end of 44 weeks of age, 10 blood samples per treatment (2 samples per replicate) were collected from the brachial vein (5 mL/hen) using heparinized syringes. One mL of each blood sample was centrifuged at 2000x g for 10 min at 4 °C to separate and store plasma at −20 °C to determine corticosterone concentration. Meanwhile, the 4 mL of each sample was used to isolate the peripheral blood mononuclear cells (PBMCs) as reported by Mehaisen et al. [36]. Briefly, the PBMCs were washed twice using cell culture medium (Gibco RPMI 1640 Medium, Thermo Fisher Scientific, Waltham, MA, USA), to remove the residual platelets, and re-suspended with phosphate-buffered saline (PBS) (pH 7.2). Then, 1 mL of cell suspension was centrifuged for 20 min at 1030x g for 20 min and the aggregated granules obtained were stored at −70 °C for further analyses (TNF-α, interleukin 1β (IL-1β), malondialdehyde (MDA), total antioxidant capacity (TAC), super oxide dismutase (SOD) and forkhead box O3 (Foxo3) expression).
2.4. Productive Performance
Daily egg numbers, egg weights and feed intake (g/hen/d) were recorded for each experimental group for one week post E. coli challenge. Feed conversion was then calculated, as g feed intake/g egg mass.
2.5. Propolis Phenolic Content and Free Radical Scavenging Activity
Propolis total phenolic acids and flavonoids contents were analyzed using high-performance liquid chromatography (HPLC) (Agilent 1260 Infinity, Santa Clara, CA, USA) as previously described [31]. All the chemicals used were HPLC grade. Sample separation was carried out using 20 μL sample injection volume with flow rate of 1 mL/min. The retention time of sample against reference standard was used to identify and quantify the eluted components.
The absorption wavelength was set at 284 nm. The antioxidant activity of propolis was measured using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay according to Shimada et al. [37]. Briefly, 1 mL of the solution (0.1 mM of DPPH dissolved in methanol) was added to 3 mL of PR solution at different concentrations (0.78–100 µM). The mixture was well-stirred and kept in darkness at room temperature. After 30 min of incubation, samples absorbance was detected at 517 nm according to Oktay et al. [38]. Propolis phenolic and flavonoid contents as well as free radical scavenging activity (DPPH) are presented in Figure 1a,b.
Modulating Laying Hens Productivity and Immune Performance in Response to Oxidative Stress Induced by E. coli Challenge Using Dietary Propolis Supplementation - Image 1
2.6. Physiological Parameters
2.6.1. Inflammation Markers and Antioxidant Parameters in PBMCs
The stored PBMCs were washed and re-suspended with 1 mL of PBS, kept on ice for one minute and then sonicated for another one minute. The obtained homogenate was centrifuged at 1030× g and 4 °C for 15 min. The collected supernatants were used to quantify the inflammatory cytokines and antioxidant parameters levels. TNF-α and IL-1β levels were measured using chicken specific enzymatic-linked immunosorbent assay (ELISA) diagnostic kit supplied by MyBioSource, San Diego, CA, USA (cat# MBS2509660 and MBS761055, respectively). While, malondialdehyde, total antioxidant capacity and superoxide dismutase levels were determined using quantitative colorimetric assay kits supplied by Abcam, Cambridge, UK (cat# ab118970, ab65329 and ab65354 respectively).
2.6.2. Plasma Corticosterone Hormone Assay
Plasma corticosterone levels were quantified (n = 10, 2 samples per replicate) using ELISA kits specific for chicken (cat# MBS701668; MyBioSource, San Diego, CA, USA). According to the manufacturer, the intra-assay and inter-assay coefficient of variability were <8% and <10%, respectively, with dynamic range of 0.5 to 20 ng/mL.
2.7. Immunological Parameters
2.7.1. Wattle Thickness in Response to Phytohemagglutinin-P (PHA) Antigen Injection
Wattle thickness response to phytohemagglutinin-P (PHA) antigen injection was performed as described by Edelman et al. [39]. Briefly, a solution of PHA was prepared by dissolving 100 µg in 0.1 mL of sterile PBS buffer. The hens were injected (n = 10; 2 birds per replicate) in the center of the wattle with 50 µL of the PHA solution. To assess cell-mediated immune response, wattle thickness was measured using a caliper (Schnelltester automatic caliper) both before and 24 h after PHA injection.
2.7.2. Total WBC Count and Heterophile/Lymphocyte (H/L) Ratio Determination
Total leukocyte counts in the whole blood for 10 samples per treatment (2 samples per replicate) were performed manually using a hemocytometer slide as described by Gehad et al. [40]. Meanwhile, H/L ratio was determined manually according to the avian guidelines [41], using Hema-3 stain (cat# 22–122,911, Fisher Scientific, Pittsburg, PA, USA). After staining, H/L ratios were calculated by the differential leukocyte counting (200 leukocytes; heterophil against lymphocyte) which was performed by using light microscope at a magnification of 100x with oil immersion.
2.7.3. Peripheral T- and B-Lymphocyte Proliferation
The stimulating index (SI) of T- and B-lymphocyte proliferation was calculated according to Mehaisen et al. [34]. The method, in brief, started with washing PBMCs (n = 10; 2 samples per replicate) in RPMI 1640 culture medium and viable lymphocytes were detected (using Trypan Blue dye; cat# T8154, Sigma-Aldrich, St. Luis, MO, USA). The viable cells were then plated in triplicate at 6 x 106 cells per well using 96-well plate. Then, 50 μL of either concanavalin-A at a concentration of 45 μg/ mL (cat# C5275, Sigma-Aldrich, St. Luis, MO, USA) or lipopolysaccharide at a concentration of 10 μg/mL (cat# L4391, Sigma-Aldrich, St. Luis, MO, USA) was added to stimulate T-cells and B-cells proliferation, respectively. Meanwhile, 50 μL of RPMI-1640 medium (Gibco, Thermo Fisher Scientific, Waltham, MA, USA) was added to the un-stimulated cells (control). Cells were incubated with 5% CO2 at 42 °C for two days. Afterwards, 15 μL of 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) (cat# M2128, Sigma-Aldrich, St. Louis, MO, USA) was added at a concentration of 5 mg/mL to each well, then cells were incubated at 42 °C. Four hours later after incubation, 100 μL of 10% sodium dodecyl sulfate, dissolved in 0.04 M HCl, was added per well. The absorbance was detected at 570 nm using ChroMate Microplate Reader-4300 (Awareness Technology Inc., Palm City, FL, USA). T- and B-lymphocytes SI was calculated as the optical density ratio of stimulated cells to un-stimulated control cells.
2.8. Small Intestine Histomorphology
Ileum sections of the small intestinal samples were collected from hens after cervical dislocation (n = 5; one sample per replicate) as described by Mehaisen et al. [33]. Samples were thoroughly washed and soaked for 72 h in 10% neutral buffered formalin. Cross sections (thickness was 3–5 μm) were obtained, by a rotatory microtome, and stained using general staining method with Harris hematoxylin and eosin stain [42]. The villus height and crypts depth of sample sections were examined and determined under light microscope at 40x magnification using image analysis software (Leica Microsystems, Wetzlar, Germany).
2.9. Leucocyte Cell Viability
Leucocyte cell viability (n = 10; 2 samples per replicate) was measured using a modified MTT assay [43]. Briefly, 5 mg of tetrazolium salt MTT (Serva, Heidelberg, Germany) was dissolved in 1 mL of AIM-V medium. Using a 98-well plate, 100 μL of cell culture medium was supplemented with 25 μL of (5 mg/mL) MTT solution, and the cells were then incubated for 4 h at 37 °C. After incubation, the plates were centrifuged for 10 min at 600x g, and the incubation medium was aspirated. Acidified isopropyl alcohol solution (0.04 N HCl) was added to each well (100 μL) and then the absorbance of formazan was measured at 570 nm using ELISA reader.
2.10. Foxo3 Expression in PBMCs
The expression of forkhead box O3 in PBMCs supernatant was analyzed using western blotting method. The primary antibodies of β-actin (1:1000 dilution, Santa Cruz Biotechnology, Dallas, TX, USA) and Foxo3 (1:500 dilution, cat# AB12162, Abcam, San Francisco, CA, USA) were employed while the Flag-Foxo3 chicken protein source was bought from LMAI-BIO (Shanghai, China).
The polyvinylidene fluoride (PVDF) membranes were incubated overnight at 4 °C with the primary antibodies. The incubation followed by washing twice with Tris-buffer saline with 0.1% (v/v) Tween 20. Afterwards, the PVDF membrane was incubated for 2 h with horseradish peroxidase-conjugated immunoglobulin G (IgG) antibody (1:2000 dilution, Santa Cruz Biotechnology, Dallas, TX, USA) at room temperature. Chemiluminescence detection method was then conducted to obtain results.
2.11. Statistical Analysis
The obtained data were analyzed by two-way ANOVA using the general linear model (GLM) of SAS Software Package [44]. The main effect of dietary propolis supplementation (PR), E. coli challenge (EC) and their interaction (PR x EC) on the different quantitative parameters measured were assessed. When significant differences due to PR, EC or PR x EC were detected, Least Significant Difference (LSD) test was performed to determined significance among experimental groups. Statistical difference was set at p < 0.05 and results were expressed as LSM ± SEM.
3. Results
3.1. Productive Performance
Productive performance of laying hens was influenced by E. coli challenge and dietary PR supplementation (Table 1). The presented data showed a significant (p < 0.05) reduction in egg number and egg weight by 36% and 12.6%, respectively, in EC group compared to C group. Furthermore, feed intake was reduced (p < 0.05) by 25% and feed conversion was impaired (p < 0.05) by 35% with E. coli challenge compared to C group. However, dietary PR supplementation was able to (p < 0.05) reduce the negative impact of E. coli challenge on egg number, egg weight and feed intake by 20%, 7% and 18%, respectively, compared to the laying hens fed on basal diet and challenged with E. coli. However, there was no significant change in productive performance between laying hens in PR and C groups.
Modulating Laying Hens Productivity and Immune Performance in Response to Oxidative Stress Induced by E. coli Challenge Using Dietary Propolis Supplementation - Image 2
3.2. Inflammation Markers and Antioxidant Status
The changes in TNF-α, IL-1β, MDA, TAC and SOD levels in PBMCs as well as plasma corticosterone concentrations in response to E. coli or saline injection in laying hens fed on basal diet or basal diet supplemented with PR for four weeks are shown in Table 2. E. coli injection induced inflammation by significantly (p < 0.05) increasing TNF-α, IL-1β and plasma corticosterone level by 1.9, 2.9 and 2.7 folds, respectively, compared to C group. The negative effect of E. coli challenge was alleviated by providing the laying hens a diet supplemented with PR. A significant reduction (p < 0.05) was noticed in TNF-α by 13% and in both IL-1β and plasma corticosterone by 37%. Meanwhile, there were no significant differences of the studied inflammatory markers levels in PR group compared to C group.
Modulating Laying Hens Productivity and Immune Performance in Response to Oxidative Stress Induced by E. coli Challenge Using Dietary Propolis Supplementation - Image 3
Changes in oxidative status were identified in PBMCs by screening MDA, TAC and SOD levels (Table 2). The MDA levels increased (p < 0.05) by 2.2-folds and TAC decreased significantly (p < 0.05) by 34% while the SOD concentration did not change in EC group compared to C group. However, adding PR to the basal diet minimized (p < 0.05) the elevation of MDA concentration induced by E. coli challenge by 45% in PR + EC group and retuned back to the normal level compared to control. Furthermore, data showed that dietary PR supplementation in PR group caused a significant (p < 0.05) improvement in the antioxidant status by increasing the concentration of TAC and SOD, by 84% and 20%, respectively, compared to C group.
3.3. Immunological Performance
The data in Table 3 demonstrated that laying hens fed on a basal diet and exposed to E. coli challenge showed suppression of all immunological measured parameters compared to other experimental groups, while the dietary PR supplemented group was able to reverse the negative effects induced by E. coli challenge. Total white blood cells (TWBCs) were reduced (p < 0.05) by 35.5% and 15.8%, while heterophile/lymphocyte (H/L) ratio was increased (p < 0.05) by 2.6 and 1.8 folds in EC and PR + EC groups, respectively, compared to C group. Wattle thickness in response to PHA injection was decreased (p < 0.05) by 20% in EC group compared to C group. Furthermore, the lymphocyte proliferation of T-cells was suppressed (p < 0.05) by 2.7-folds and 29.5% and B-cell proliferation was inhibited (p < 0.05) by 2-folds and 15.8%, respectively, in EC and PR + EC groups, compared to control. On the other hand, dietary propolis supplementation in PR group significantly elevated these immunological parameters except for H/L ratio compared to C group.
Modulating Laying Hens Productivity and Immune Performance in Response to Oxidative Stress Induced by E. coli Challenge Using Dietary Propolis Supplementation - Image 4
3.4. Small Intestines Histomorphology
The change of villi height, crypt depth and their ratio in response to E. coli challenge and dietary PR supplementation in laying hens are presented in Table 4. E. coli challenge showed no significant (p ≥ 0.05) changes in villi height or crypt depth compared to C group. However, dietary PR supplementation, with or without E. coli challenge, caused a significant increase (p < 0.05) of villi height (Figure 2). Meanwhile, there was no significant effect on crypt depth or their ratio compared to C group.
Modulating Laying Hens Productivity and Immune Performance in Response to Oxidative Stress Induced by E. coli Challenge Using Dietary Propolis Supplementation - Image 5
 
Modulating Laying Hens Productivity and Immune Performance in Response to Oxidative Stress Induced by E. coli Challenge Using Dietary Propolis Supplementation - Image 6
3.5. Leucocyte Cell Viability and Foxo3 Expression
Leucocyte cell viability percentage (CV%) was significantly decreased (p < 0.05) with E. coli challenge (Figure 3a) in EC group. Whereas, dietary PR supplementation was able to significantly (p < 0.05) alleviate the negative effect induced by E. coli challenge in PR + EC group on CV% and returned back to the normal level in C group. On the other hand, dietary PR supplementation in PR group significantly (p < 0.05) increased CV% by 40% compared to C group. Moreover, the level of Foxo3 protein expression was influenced by E. coli challenge and dietary PR supplementation (Figure 3b). E. coli challenge induced over-expression of Foxo3 in EC group compared to C group. However, dietary propolis supplementation in PR and PR + EC groups normalized the Foxo3 expression to similar levels of the C group. It is worth to notice that the concentration of Foxo3 protein negatively correlated with CV% values.
Modulating Laying Hens Productivity and Immune Performance in Response to Oxidative Stress Induced by E. coli Challenge Using Dietary Propolis Supplementation - Image 7
4. Discussion
Pathogenic bacterial infection imposes a huge physiological stress on birds. The negative impact of APEC infection on poultry production is mediated by endotoxin release [45] and oxidative stress generation [46]. The present results showed impairment in laying hen production with E. coli administration. Reduction of egg number and egg weight, in addition to low feed intake and impaired feed conversion were the major negative effects of E. coli administration (Table 1). 
Inoculation of APEC, whether intraperitoneal or intra-uterine, reported to cause a significant reduction in egg production efficiency in White Leghorn hens [47]. This negative effect could be in part mediated by the fact that E. coli induced excess production of ROS/RNS, exceeding the ability of the antioxidant defense system to cope with, which directly increase cell damage and subsequently reduce production [48]. da Rosa et al. [49] reported that the negative effect of E. coli infection on chicken growth performance was mediated by oxidative stress indicated with remarkable elevation in serum and hepatic ROS formation. On the other hand, propolis supplementation was reported to improve egg production quantitatively and qualitatively in laying Japanese quail subjected to heat induced oxidative stress [34]. The improvement in egg production with propolis supplementation may be justified by its antioxidant [50] and antimicrobial activities [51]. PR supplementation reported to increase egg production rate and shell weight as well as improve egg quality and feed conversion ratio in laying hen [52]. Moreover, Seven [53] reported that dietary PR supplementation to laying hen subjected to oxidative stress, induced by cyclic heat stress, was able to increase growth performance, nutrient digestibility, egg weight and egg shell weight as well as decrease mortality rate. The possible mechanisms of PR influencing layer productively under APEC challenge is partially mediated by its antimicrobial ability to reduce pathogenic bacterial growth in the chicken lower gastrointestinal tract [54] and improve Ca absorption and digestibility [55] due to its acid derivatives contents. Further, positive impacts of PR on layer performance may be attributed to the palatable components existed in PR such as resin, vanillin, wax and honey [56], and these components could give beneficial results when hens are kept under stress conditions [53].
Pro-inflammatory cytokines are peptides released from immune cells, mainly macrophage and T-lymphocytes, upon activation [57]. When birds confront a pathogen, inflammation is a mechanism of the innate immunity to contain the bacterium infection and reduce pathogenic threatens [58]. The significant increase in TNF-α, IL-1β, H/L ratio and plasma corticosterone levels with E. coli challenge indicate the induction of inflammation and stress responses (Tables 2 and 3). Mehaisen et al. [59] reported that intra-veins E. coli injection increased TNF-α and IL-1β genes expression by two and three folds, respectively, in the brain and liver tissues of the laying hens. It is fundamental to note that the elevation in cytokines production induces the hypothalamic-pituitary-adrenal axis which consequently increases plasma corticosterone concentration as previously described [60–62]. Mol et al. [63] suggested that the immune response of chicken lung epithelial cell line to APEC invasion depends on the up-regulation of IL-8 expression which subsequently attracts macrophages and heterophils to the infection cite. In addition, chicken macrophage-like cells showed up-regulation of different cytokines gene expression (IL-8, IL-6, IL-1β and IL-10) when incubated with APEC [62]. Blocking pro-inflammatory cytokines was suggested to potentially mitigate the negative effect of E. coli inducing intestinal inflammation in rat [64]. Propolis supplementation was reported to have the capability of reducing inflammation, suppressing cytokines production of immune cells as well as reducing corticosterone level [33,65]. The anti-inflammatory properties of propolis are mediated by its ability to reduce oxidative stress, [66] in addition to have hyaluronidase inhibitory activity [26].
Stress imposed by infectious disease induces imbalance oxidative status with excess production of ROS/RNS and lipid peroxidation. Significant increase in MDA with low TAC concentrations was observed when laying hens were challenged with E. coli (Table 2). Ayala et al. [67] linked between high levels of free radical and ROS formation and lipid peroxidation. In rats, intraperitoneal injection of LPS driven from E. coli induced lipid peroxidation and reduced glutathione, glutathione-S-transferase and SOD activities as well as TAC with a progressive increasing effect over time [68]. The cell antioxidant defense includes antioxidant enzymes (e.g., SOD, GPx and catalase) and free radical scavenging antioxidants (e.g., vitamin E and C) in addition to other enzymes and proteins involved in the repair or removal of the damaged molecules (e.g., heat shock proteins, DNA-repairing enzymes and proteasomes) [48]. Yangi et al. [69] suggested that the protective effect of propolis to LPS-induced endotoxin stress was mediated by attenuating the inflammatory response and its subsequent ROS production. Previous researches reported that propolis has a high content of phenolic acids and flavonoids [28] in addition to high antioxidant activity [31]. Furthermore, the antioxidant activities of different propolis extracts depend on their phenolic content [24,70]. This data was confirmed by the presented HPLC and DPPH results of the dietary supplemented propolis (Figure 1a,b). In the present study, the high phenolic content and free radical scavenging activity found in propolis suggested a high affinity for oxidative reduction which causes the decrease observed in MDA and the increase in TAC. It can be inferred from the present result that propolis supplementation improved oxidative status by mediating the non-enzymatic antioxidant compounds rather than increasing the concentration of endogenous antioxidant enzymes (i.e., SOD).
Villi height and crypt depth of small intestine were not affected by E. coli administration compared to the C group (Table 4). Although direct negative effect of oral administration of E. coli on gut morphology was reported with decreasing both villus width and height [16], other research reported no effect of E. coli challenge on villi height or crypt depth [71]. Nevertheless, PR supplementation increased villi height and crypt depth significantly (Table 4 and Figure 2). Dietary propolis supplementation, at 1 g/kg feed mixture, reported to significantly increase duodenal villi height and base width with no effect on crypt depth in broiler chicken [32]. In general, polyphenol-rich propolis extracts were found to strengthen the intestinal barrier in rats by activating AMP-activated protein kinase and extracellular signal-regulated kinases (ERK) signaling [72]. Xue et al. [73] reported that propolis supplementation to diabetic-induced rats modulated gut microbiota and improved intestinal epithelium tight and gap junctions.
The presented results are consistent and clearly show the negative effects of E. coli challenge on laying hen immunity. Cell mediated and humeral immunological parameters were significantly impaired with APEC challenge (Table 3). The negative effect of APEC on immune response was documented [74]. Mehaisen et al. [59] reported that the endotoxin shock induced by E. coli infection was responsible for the over-expression of apoptosis-related genes and increasing DNA damage of laying hen liver and brain cells. T-cells immuno-suppression, hypo-responsiveness and apoptosis were found to induce high ROS production in tumor cells [75]. The present results elicited severe inflammatory response to E. coli infection, with an increase in H/L ratio and high release of pro-inflammatory cytokines (TNF-α and IL-1β) (Tables 2 and 3), that were reported to induce excessive production of ROS and exacerbate oxidative stress which negatively affects T-cell signaling, activation and proliferation [76–78]. Lymphoproliferative disorders of B cells were also reported to be mediate by high levels of ROS [79]. In the meantime, Wagner et al. [80] found correlation between humeral immune responses reduction and high frequencies of late-differentiated effector, memory effector and regulatory T-lymphocytes. Propolis supplementation significantly alleviates, to some extent, the negative effects of E. coli on laying immunity (Table 3). Furthermore, propolis supplementation to non-challenged hens significantly induced T- and B-lymphocytes proliferation. These effects may be mediated by the rich polyphenol content of propolis that helped in relieving ROS accumulation and inflammation to the extent that they, subsequently, activate T-cell proliferation [50]. These advantages of propolis on immune response can be justified by the capability of propolis and its bioactive compound to reduce inflammation and subsequently enhance immune response [35,65,81].
Leucocytes cell viability was significantly reduced by 29% in EC and by 12% in PR + EC groups (Figure 3a). These results can be justified by the endotoxin stress imposed by APEC which reported to induce DNA damage in the liver and brain cells and apoptosis in laying hens [59]. Besides, Foxo3 protein, a transcription factor that has been related to reduction of cell proliferation [82] and cell death [83], was over-expressed with the E. coli challenge (Figure 3b). It has been found that Foxo1/3 is expressed in different immune cell types with high expression in T- and B-lymphocytes and very low levels in macrophage [84]. They concluded that a cascade involving kinase Mst-Foxo/nuclear factor 2 (Nrf2) signaling pathway is important for attenuating ROS-induced immune cell damage and pathological states including infection diseases. Up regulation of Foxo3 was reported to modulate helper T cell quiescence [85] and increase T-lymphocyts apoptosis [86]. Bi et al. [87] indicated that Foxo1, Foxo3 and Foxo4 are key genes in inhibiting lymphocyte cell proliferation of chicken infected with reticuloendotheliosis virus. It can be inferred that the over-expression of Foxo3 protein has a major contribution in the observed CV% reduction [88]. Taking altogether, these results suggested that propolis supplementation, attributed to its antioxidant properties, successfully managed to return the oxidation balance to immune cells by lowering Foxo3 expression and increasing CV%.
5. Conclusions
Pathogenic bacteria challenge is a major worldwide concern, especially with the increasing hazard of spreading antibiotic-resistance genes. The present results established solid evidence of the negative effects of E. coli administration on oxidative status, immune response and production performance of laying hens. Furthermore, APEC infection not only induced pro-inflammation response but also caused imbalance redox status and excessive ROS production. However, propolis supplementation at 0.1% of the diet improved oxidative status and immune response, simultaneously restoring the absent balance caused by E. coli infection. The positive influences of antioxidant compounds in the PR can reduce the MDA, IL-1β and corticosterone levels. Furthermore, PR was able to normalize the high expression level of Foxo3 and productive performance in layers exposed to EC. In addition, PR reduced inflammation reaction and enhanced leucocytes cells proliferation and viability. Thus, dietary PR can be used effectively as a natural product to bring back redox status balance and protect individuals from endotoxins, oxidative stress and immunosuppression imposed by pathogenic bacterial infection while avoiding the generating hazard of antibiotic resistant bacteria.
Author Contributions: Conceptualization, A.O.A. and A.A.A.; Data curation, A.O.A.; Formal analysis, N.N.K.;Funding acquisition, A.A.A.; Investigation, H.K.A.E.-A.; Methodology, A.O.A. and A.A.A.; Project administration, A.O.A.; Resources, A.A.A. and H.S.E.-B.; Supervision, A.O.A.; Validation, H.S.E.-B.; Visualization, N.N.K.; Writing—original draft, N.N.K.; Writing—review & editing, A.O.A. All authors have read and agreed to the published version of the manuscript.
Funding: This research was funded by the Deputyship for Research & Innovation, Ministry of Education in SaudiArabia through the project number IFT20011.
Acknowledgments: The authors extend their appreciation to the Deputyship for Research & Innovation,Ministry of Education in Saudi Arabia for funding this research work.
Conflicts of Interest: The authors declare no conflict of interest.
This article was originally published in Antioxidants 2020, 9, 0893; doi:10.3390/antiox9090893. This is an Open Access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) License (http://creativecommons.org/licenses/by/4.0/).
  1. Saiyasit, N.; Chunchai, T.; Apaijai, N.; Pratchayasakul, W.; Sripetchwandee, J.; Chattipakorn, N.; Chattipakorn, S.C. Chronic high-fat diet consumption induces an alteration in plasma/brain neurotensin signaling, metabolic disturbance, systemic inflammation/oxidative stress, brain apoptosis, and dendritic spine loss. Neuropeptides 2020, 82, 102047. [CrossRef] [PubMed]
  2. Singh, A.; Tripathi, P.; Yadawa, A.K.; Singh, S. Promising Polyphenols in Parkinson’s Disease Therapeutics. Neurochem. Res. 2020, 45, 1731–1745. [CrossRef] [PubMed]
  3. Son, E.S.; Park, J.-W.; Kim, Y.J.; Jeong, S.H.; Hong, J.H.; Kim, S.-H.; Kyung, S.Y. E ects of antioxidants on oxidative stress and inflammatory responses of human bronchial epithelial cells exposed to particulate matter and cigarette smoke extract. Toxicol. In Vitro 2020, 67, 104883. [CrossRef] [PubMed]
  4. Petushkova, A.I.; Zamyatnin, J.A.A. Redox-Mediated Post-Translational Modifications of Proteolytic Enzymes and Their Role in Protease Functioning. Biomolecules 2020, 10, 650. [CrossRef]
  5. Pizzino, G.; Irrera, N.; Cucinotta, M.; Pallio, G.; Mannino, F.; Arcoraci, V.; Squadrito, F.; Altavilla, D.; Bitto, A. Oxidative Stress: Harms and Benefits for Human Health. Oxidative Med. Cell. Longev. 2017, 2017, 1–13. [CrossRef] [PubMed]
  6. Raphael, I.; Nalawade, S.; Eagar, T.N.; Forsthuber, T.G. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine 2014, 74, 5–17. [CrossRef]
  7. Enany, M.E.; Algammal, A.M.; Nasef, S.A.; Abo-Eillil, S.A.M.; Bin-Jumah, M.N.; Taha, A.E.; Allam, A.A. The occurrence of the multidrug resistance (MDR) and the prevalence of virulence genes and QACs resistance genes in E. coli isolated from environmental and avian sources. AMB Express 2019, 9, 1–9. [CrossRef] [PubMed]
  8. Al Azad, M.A.R.; Rahman, M.; Amin, R.; Begum, M.I.A.; Fries, R.; Husna, A.; Khairalla, A.S.; Badruzzaman, A.; El Zowalaty, M.E.; Na Lampang, K.; et al. Susceptibility and Multidrug Resistance Patterns of Escherichia coli Isolated from Cloacal Swabs of Live Broiler Chickens in Bangladesh. Pathogens 2019, 8, 118. [CrossRef]
  9. Muloi, D.; Kiiru, J.; Ward, M.J.; Hassell, J.M.; Bettridge, J.M.; Robinson, T.P.; Van Bunnik, B.A.; Chase-Topping, M.; Robertson, G.; Pedersen, A.B.; et al. Epidemiology of antimicrobial-resistant Escherichia coli carriage in sympatric humans and livestock in a rapidly urbanizing city. Int. J. Antimicrob. Agents 2019, 54, 531–537. [CrossRef]
  10. Zbikowska,˙ K.; Michalczuk, M.; Dolka, B. The Use of Bacteriophages in the Poultry Industry. Animals 2020, 10, 872. [CrossRef]
  11. Franklin, N.; Hope, K.; Glasgow, K.; Glass, K. Describing the Epidemiology of Foodborne Outbreaks in New South Wales from 2000 to 2017. Foodborne Pathog. Dis. 2020. [CrossRef] [PubMed]
  12. Ibrahim, R.A.; Cryer, T.L.; Lafi, S.; Abu-Basha, E.A.; Good, L.; Tarazi, Y.H. Identification of Escherichia coli from broiler chickens in Jordan, their antimicrobial resistance, gene characterization and the associated risk factors. BMC Veter. Res. 2019, 15, 159. [CrossRef]
  13. Yan, W.; Bai, R.; Wang, S.; Tian, X.; Li, Y.; Wang, S.; Yang, F.; Xiao, Y.; Lu, X.; Zhao, F. Antibiotic resistance genes are increased by combined exposure to sulfamethoxazole and naproxen but relieved by low-salinity. Environ. Int. 2020, 139, 105742. [CrossRef] [PubMed]
  14. Han, T.; Zhang, Q.; Liu, N.; Wang, J.; Li, Y.; Huang, X.; Liu, J.; Wang, J.; Qu, Z.; Qi, K. Changes in antibiotic resistance of Escherichia coli during the broiler feeding cycle. Poult. Sci. 2020. [CrossRef]
  15. Kumari, M.; Gupta, R.P.; Lather, D.; Bagri, P. Ameliorating e ect of Withania somnifera root extract in Escherichia coli–infected broilers. Poult. Sci. 2020, 99, 1875–1887. [CrossRef] [PubMed]
  16. Daneshmand, A.; Kermanshahi, H.; Sekhavati, M.H.; Javadmanesh, A.; Ahmadian, M. Antimicrobial peptide, cLF36, a ects performance and intestinal morphology, microflora, junctional proteins, and immune cells in broilers challenged with E. coli. Sci. Rep. 2019, 9, 14176–14179. [CrossRef]
  17. Ramadan, H.; Jackson, C.R.; Frye, J.G.; Hiott, L.M.; Samir, M.; Awad, A.; Woodley, T.A. Antimicrobial Resistance, Genetic Diversity and Multilocus Sequence Typing of Escherichia coli from Humans, Retail Chicken and Ground Beef in Egypt. Pathogens 2020, 9, 357. [CrossRef]
  18. Hazrati, S.; Rezaeipour, V.; Asadzadeh, S. E ects of phytogenic feed additives, probiotic and mannan-oligosaccharides on performance, blood metabolites, meat quality, intestinal morphology, and microbial population of Japanese quail. Br. Poult. Sci. 2019, 61, 132–139. [CrossRef]
  19. Dong, Y.; Li, R.; Liu, Y.; Ma, L.; Zha, J.; Qiao, X.; Chai, T.; Wu, B. Benefit of Dietary Supplementation with Bacillus subtilis BYS2 on Growth Performance, Immune Response, and Disease Resistance of Broilers. Probiot. Antimicrob. Proteins 2020. [CrossRef]
  20. Makled, M.N.; Abouelezz, K.; Gad-Elkareem, A.E.G.; Sayed, A.M. Comparative influence of dietary probiotic, yoghurt, and sodium butyrate on growth performance, intestinal microbiota, blood hematology, and immune response of meat-type chickens. Trop. Anim. Health Prod. 2019, 51, 2333–2342. [CrossRef]
  21. Zhan, H.; Dong, X.; Li, L.; Zheng, Y.; Gong, Y.; Zou, X. E ects of dietary supplementation with Clostridium butyricum on laying performance, egg quality, serum parameters, and cecal microflora of laying hens in the late phase of production. Poult. Sci. 2019, 98, 896–903. [CrossRef]
  22. Simone-Finstrom, M.; Borba, R.S.; Wilson, M.; Spivak, M. Propolis Counteracts Some Threats to Honey Bee Health. Insects 2017, 8, 46. [CrossRef]
  23. Rivero-Cruz, J.F.; Granados-Pineda, J.; Pedraza-Chaverri, J.; Rojas, J.M.P.; Passari, A.K.; Díaz-Ruiz, G.; Rivero-Cruz, B.E. Phytochemical Constituents, Antioxidant, Cytotoxic, and Antimicrobial Activities of the Ethanolic Extract of Mexican Brown Propolis. Antioxidants 2020, 9, 70. [CrossRef] [PubMed]
  24. Galeotti, F.; Maccari, F.; Fachini, A.; Volpi, N. Chemical Composition and Antioxidant Activity of Propolis Prepared in Di erent Forms and in Di erent Solvents Useful for Finished Products. Foods 2018, 7, 41. [CrossRef]
  25. Wo´zniak, M.; Mrówczynska,´ L.; Wa´skiewicz, A.; Rogozinski,´ T.; Ratajczak, I. Phenolic Profile and Antioxidant Activity of Propolis Extracts from Poland. Nat. Prod. Commun. 2019, 14. [CrossRef]
  26. Osés, S.; Marcos, P.; Azofra, P.; De Pablo, A.; Fernández-Muíño, M.A.; Sancho, M.T. Phenolic Profile, Antioxidant Capacities and Enzymatic Inhibitory Activities of Propolis from Di erent Geographical Areas: Needs for Analytical Harmonization. Antioxidants 2020, 9, 75. [CrossRef] 
  27. Kuo, Y.-H.; Chiang, H.-L.; Wu, P.-Y.; Chu, Y.; Chang, Q.-X.; Wen, K.-C.; Lin, C.-Y.; Chiang, H.-M. Protection against Ultraviolet A-Induced Skin Apoptosis and Carcinogenesis through the Oxidative Stress Reduction E ects of N-(4-bromophenethyl) Ca eamide, A Propolis Derivative. Antioxidants 2020, 9, 335. [CrossRef]
  28. Ramanauskiene,˙ K.; Inkenien˙e,˙ A.M.; Petrikaite,˙ V.; Briedis, V. Total Phenolic Content and Antimicrobial Activity of Di erent Lithuanian Propolis Solutions. Evid. Based Complement. Altern. Med. 2013, 2013, 1–5. [CrossRef]
  29. Park, E.-H.; Kim, S.-H.; Park, S.-S. Anti-inflammatory activity of propolis. Arch. Pharm. Res. 1996, 19, 337–341. [CrossRef]
  30. Campos, J.F.; Dos Santos, E.L.; da Rocha, P.D.S.; Damião, M.J.; Balestieri, J.B.P.; Cardoso, C.A.L.; Paredes-Gamero, E.J.; Estevinho, L.M.; Souza, K.D.P.; Dos Santos, E.L. Antimicrobial, Antioxidant, Anti-Inflammatory, and Cytotoxic Activities of Propolis from the Stingless Bee Tetragonisca fiebrigi (Jataí). Evid. Based Complement. Altern. Med. 2015, 2015, 1–11. [CrossRef] 
  31. Abass, A.O.; Kamel, N.; Khalifa, W.; Gouda, G.F.; El-Manylawi, M.A.F.; Mehaisen, G.M.K.; Mashaly, M.M. Propolis supplementation attenuates the negative e ects of oxidative stress induced by paraquat injection on productive performance and immune function in turkey poults. Poult. Sci. 2017, 96, 4419–4429. [CrossRef] [PubMed]
  32. Prakatur, I.; Miškulin, M.; Pavic, M.; Marjanovic, K.; Blazicevic, V.; Miškulin, M.; Domacinovic, M. Intestinal Morphology in Broiler Chickens Supplemented with Propolis and Bee Pollen. Animals 2019, 9, 301. [CrossRef] [PubMed]
  33. Mehaisen, G.M.K.; Ibrahim, R.M.; Desoky, A.A.; Safaa, H.; El-Sayed, O.A.; Abass, A.O. The importance of propolis in alleviating the negative physiological effects of heat stress in quail chicks. PLoS ONE 2017, 12, e0186907. [CrossRef] [PubMed]
  34. Mehaisen, G.M.K.; Desoky, A.A.; Sakr, O.G.; Sallam, W.; Abass, A.O. Propolis alleviates the negative e ects of heat stress on egg production, egg quality, physiological and immunological aspects of laying Japanese quail. PLoS ONE 2019, 14, e0214839. [CrossRef] [PubMed]
  35. AlQarni, A.M.; Niwasabutra, K.; Sahlan, M.; Fearnley, H.; Ferro, V.; Watson, D.G. Propolis Exerts an Anti-Inflammatory E ect on PMA-Di erentiated THP-1 Cells via Inhibition of Purine Nucleoside Phosphorylase. Metabolites 2019, 9, 75. [CrossRef]
  36. Mehaisen, G.M.K.; Eshak, M.G.; Elkaiaty, A.M.; Atta, A.M.; Mashaly, M.M.; Abass, A.O. Comprehensive growth performance, immune function, plasma biochemistry, gene expressions and cell death morphology responses to a daily corticosterone injection course in broiler chickens. PLoS ONE 2017, 12, e0172684. [CrossRef]
  37. Shimada, K.; Fujikawa, K.; Yahara, K.; Nakamura, T. Antioxidative properties of xanthan on the autoxidation of soybean oil in cyclodextrin emulsion. J. Agric. Food Chem. 1992, 40, 945–948. [CrossRef]
  38. Oktay, M.; Gülçin, I.; Küfrevioglu,˘ Ö.I. Determination of in vitro antioxidant activity of fennel (Foeniculum vulgare) seed extracts. LWT 2003, 36, 263–271. [CrossRef]
  39. Edelman, A.S.; Sánchez, P.L.; Robinson, M.E.; Hochwald, G.M.; Thorbecke, G. Primary and Secondary Wattle Swelling Response to Phytohemagglutinin as a Measure of Immunocompetence in Chickens. Avian Dis. 1986, 30, 105. [CrossRef]
  40. Gehad, A.E.; Mehaisen, G.M.K.; Abbas, A.O.; Mashaly, M.M. The Role of Light Program and Melatonin on Alleviation of Inflammation Induced by Lipopolysaccharide Injection in Broiler Chickens. Int. J. Poult. Sci. 2008, 7, 193–201. [CrossRef]
  41. Campbell, T.W. Hematology. In Avian Medicine: Principles and Application; Ritchie, B.W., Harrison, G.J., Harrison, L.R., Eds.; Winger’s Publishing Inc.: Lake Worth, FL, USA, 1994; pp. 176–198.
  42. Suvarna, S.K.; Layton, C.; Bancroft, J.D. Bancroft’s Theory and Practice of Histological Techniques, 8th ed.; Elsevier Ltd.: Amsterdam, The Netherlands, 2019; p. 584. [CrossRef]
  43. Reinhold, D.; Bank, U.; Bühling, F.; Neubert, K.; Mattern, T.; Ulmer, A.J.; Flad, H.-D.; Ansorge, S. Dipeptidyl Peptidase IV (CD26) on Human Lymphocytes. Synthetic Inhibitors of and Antibodies against Dipeptidyl Peptidase IV Suppress the Proliferation of Pokeweed Mitogen-Stimulated Peripheral Blood Mononuclear Cells, and IL-2 and IL-6 Production. Immunobiology 1993, 188, 403–414. [CrossRef]
  44. SAS Institute Inc. SAS/STATR 9.3 User’s Guide; SAS Institute Inc.: Cary, NC, USA, 2004.
  45. Kirikae, T.; Kirikae, F.; Saito, S.; Tominaga, K.; Tamura, H.; Uemura, Y.; Yokochi, T.; Nakano, M. Biological Characterization of Endotoxins Released from Antibiotic-Treated Pseudomonas aeruginosa and Escherichia coli. Antimicrob. Agents Chemother. 1998, 42, 1015–1021. [CrossRef] [PubMed]
  46. Mahmoud, K.Z.; Edens, F. Influence of organic selenium on hsp70 response of heat-stressed and enteropathogenic Escherichia coli-challenged broiler chickens (Gallus gallus). Comp. Biochem. Physiol. Part C Toxicol. Pharmacol. 2005, 141, 69–75. [CrossRef] [PubMed]
  47. Chaudhari, A.A.; Kariyawasam, S. An Experimental Infection Model for Escherichia coli Egg Peritonitis in Layer Chickens. Avian Dis. 2014, 58, 25–33. [CrossRef]
  48. Surai, P.; Kochish, I.I.; Fisinin, V.I.; Kidd, M. Antioxidant Defence Systems and Oxidative Stress in Poultry Biology: An Update. Antioxidants 2019, 8, 235. [CrossRef]
  49. Da Rosa, G.; Alba, D.F.; Silva, A.D.; Gris, A.; Mendes, R.E.; Mostardeiro, V.B.; Lopes, T.F.; Schetinger, M.R.C.; Stefani, L.M.; Lopes, M.T.; et al. Impact of Escherichia coli infection in broiler breeder chicks: The e ect of oxidative stress on weight gain. Microb. Pathog. 2019, 139, 103861. [CrossRef]
  50. Asgharpour, F.; Moghadamnia, A.A.; Motallebnejad, M.; Nouri, H.R. Propolis attenuates lipopolysaccharide-induced inflammatory responses through intracellular ROS and NO levels along with downregulation of IL-1 and IL-6 expressions in murine RAW 264.7 macrophages. J. Food Biochem. 2019, 43, e12926. [CrossRef]
  51. Stepanovi´c, S.; Anti´c, N.; Daki´c, I.; Švabi´c-Vlahovi´c, M. In vitro antimicrobial activity of propolis and synergism between propolis and antimicrobial drugs. Microbiol. Res. 2003, 158, 353–357. [CrossRef]
  52. Abdel-Kareem, A.A.A.; El-Sheikh, T.M. Impact of supplementing diets with propolis on productive performance, egg quality traits and some haematological variables of laying hens. J. Anim. Physiol. Anim. Nutr. 2015, 101, 441–448. [CrossRef]
  53. Seven, P.T. The E ects of Dietary Turkish Propolis and Vitamin C on Performance, Digestibility, Egg Production and Egg Quality in Laying Hens under Di erent Environmental Temperatures. Asian Australas. J. Anim. Sci. 2008, 21, 1164–1170. [CrossRef]
  54. Kaˇcániová, M.; Rovná, K.; Arpášová, H.; Cubon,ˇˇ J.; Hleba, L.; Pochop, J.; Kunová, S.; Hašˇcík, P. In vitroandIn vivoantimicrobial activity of propolis on the microbiota from gastrointestinal tract of chickens. J. Environ. Sci. Health Part A 2012, 47, 1665–1671. [CrossRef]
  55. Mahmoud, U.T.; Cheng, H.; Applegate, T. Functions of propolis as a natural feed additive in poultry. Worlds Poult. Sci. J. 2016, 72, 37–48. [CrossRef]
  56. The Effect of Diet Propolis Supplementation on Ross Broiler Chicks Performance. Int. J. Poult. Sci. 2006, 5, 84–88. [CrossRef]
  57. Zhang, J.M.; An, J. Cytokines, Inflammation, and Pain. Int. Anesthesiol. Clin. 2007, 45, 27–37. [CrossRef]
  58. Lauridsen, C. From oxidative stress to inflammation: Redox balance and immune system. Poult. Sci. 2019, 98, 4240–4246. [CrossRef]
  59. Mehaisen, G.M.K.; Eshak, M.G.; El Sabry, M.; Abass, A.O. Expression of Inflammatory and Cell Death Program Genes and Comet DNA Damage Assay Induced by Escherichia coli in Layer Hens. PLoS ONE 2016, 11, e0158314. [CrossRef]
  60. Turnbull, A.V.; Rivier, C. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: Actions and mechanisms of action. Physiol. Rev. 1999, 79, 1–71. [CrossRef]
  61. Løtvedt, P.; Fallahshahroudi, A.; Bektic, L.; Altimiras, J.; Jensen, P. Chicken domestication changes expression of stress-related genes in brain, pituitary and adrenals. Neurobiol. Stress 2017, 7, 113–121. [CrossRef]
  62. Peng, L.; Matthijs, M.G.; Haagsman, H.P.; Veldhuizen, E.J. Avian pathogenic Escherichia coli-induced activation of chicken macrophage HD11 cells. Dev. Comp. Immunol. 2018, 87, 75–83. [CrossRef]
  63. Mol, N.; Peng, L.; Esnault, E.; Quéré, P.; Haagsman, H.P.; Veldhuizen, E.J. Avian pathogenic Escherichia coli infection of a chicken lung epithelial cell line. Veter. Immunol. Immunopathol. 2019, 210, 55–59. [CrossRef]
  64. Kittana, H.; Neto, J.C.G.; Heck, K.; Geis, A.L.; Muñoz, R.R.S.; Cody, L.A.; Schmaltz, R.J.; Bindels, L.B.; Sinha, R.; Hostetter, J.M.; et al. Commensal Escherichia coli Strains Can Promote Intestinal Inflammation via Di erential Interleukin-6 Production. Front. Immunol. 2018, 9, 2318. [CrossRef] [PubMed]
  65. Ansorge, S.; Reinhold, D.; Lendeckel, U. Propolis and Some of its Constituents Down-Regulate DNA Synthesis and Inflammatory Cytokine Production but Induce TGF- 1 Production of Human Immune Cells. Z. Nat. C 2003, 58, 580–589. [CrossRef] [PubMed]
  66. Seven, P.T.; Yilmaz, S.; Seven, I.; Kelestemur, G.T. The E ects of Propolis in Animals Exposed Oxidative Stress. In Oxidative Stress—Environmental Induction and Dietary Antioxidants; Lushchak, V.I., Ed.; InTech: London, UK, 2012; pp. 267–288. [CrossRef]
  67. Ayala, A.; Muñoz, M.F.; Arguelles, S. Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal. Oxidative Med. Cell. Longev. 2014, 2014, 1–31. [CrossRef]
  68. Halawa, A.A.; El-Adl, M.A.; Hamed, M.F.; Balboula, A.Z.; Elmetwally, M. Lipopolysaccharide Prompts Oxidative Stress and Apoptosis in Rats’ Testicular Tissue. J. Veter. Health 2018, 1, 20–31. [CrossRef]
  69. Yangi, B.; Ustuner, M.C.; Dinçer, M.; Özbayer, C.; Tekin, N.; Üstüner, D.; Colak, E.; Kolac, U.K.; Entok, E. Propolis Protects Endotoxin Induced Acute Lung and Liver Inflammation Through Attenuating Inflammatory Responses and Oxidative Stress. J. Med. Food 2018, 21, 1096–1105. [CrossRef]
  70. Kocot, J.; Kiełczykowska, M.; Luchowska-Kocot, D.; Kurzepa, J.; Musik, I. Antioxidant Potential of Propolis, Bee Pollen, and Royal Jelly: Possible Medical Application. Oxidative Med. Cell. Longev. 2018, 2018, 1–29. [CrossRef]
  71. Wang, S.; Peng, Q.; Jia, H.M.; Zeng, X.F.; Zhu, J.L.; Hou, C.L.; Liu, X.T.; Yang, F.J.; Qiao, S.Y. Prevention of Escherichia coli infection in broiler chickens with Lactobacillus plantarum B1. Poult. Sci. 2017, 96, 2576–2586. [CrossRef]
  72. Wang, K.; Jin, X.; Chen, Y.; Song, Z.; Jiang, X.; Hu, F.-L.; Conlon, M.A.; Topping, D.L. Polyphenol-rich propolis extracts strengthen intestinal barrier function by activating AMPK and ERK signaling. Nutrients 2016, 8, 272. [CrossRef]
  73. Xue, M.; Liu, Y.; Xu, H.; Zhou, Z.; Ma, Y.; Sun, T.; Liu, M.; Zhang, H.-Q.; Liang, H. Propolis modulates the gut microbiota and improves the intestinal mucosal barrier function in diabetic rats. Biomed. Pharmacother. 2019, 118, 109393. [CrossRef]
  74. Marshall, J.C.; Christou, N.V.; Meakins, J.L. Small-bowel bacterial overgrowth and systemic immunosuppression in experimental peritonitis. Surgery 1988, 104, 404–411.
  75. Chen, X.; Song, M.; Zhang, B.; Zhang, Y. Reactive Oxygen Species Regulate T Cell Immune Response in the Tumor Microenvironment. Oxidative Med. Cell. Longev. 2016, 2016, 1–10. [CrossRef] [PubMed]
  76. Larbi, A.; Kempf, J.; Pawelec, G. Oxidative stress modulation and T cell activation. Exp. Gerontol. 2007, 42, 852–858. [CrossRef] [PubMed]
  77. Moro-García, M.A.; Mayo, J.C.; Sainz, R.M.; Alonso-Arias, R. Influence of Inflammation in the Process of T Lymphocyte Di erentiation: Proliferative, Metabolic, and Oxidative Changes. Front. Immunol. 2018, 9. [CrossRef]
  78. Colitti, M.; Stefanon, B.; Gabai, G.; Gelain, M.E.; Bonsembiante, F. Oxidative Stress and Nutraceuticals in the Modulation of the Immune Function: Current Knowledge in Animals of Veterinary Interest. Antioxidants 2019, 8, 28. [CrossRef]
  79. Tohyama, Y.; Takano, T.; Yamamura, H. B cell responses to oxidative stress. Curr. Pharm. Des. 2004, 10, 835–839. [CrossRef]
  80. Wagner, A.; Garner-Spitzer, E.; Jasinska,´ J.; Kollaritsch, H.; Stiasny, K.; Kundi, M.; Wiedermann, U. Age-related di erences in humoral and cellular immune responses after primary immunisation: Indications for stratified vaccination schedules. Sci. Rep. 2018, 8, 9825. [CrossRef]
  81. Búfalo, M.C.; Ferreira, I.; Costa, G.; Francisco, V.L.G.; Liberal, J.; Cruz, M.T.; Lopes, M.; Batista, M.T.; Sforcin, J.M. Propolis and its constituent ca eic acid suppress LPS-stimulated pro-inflammatory response by blocking NF- B and MAPK activation in macrophages. J. Ethnopharmacol. 2013, 149, 84–92. [CrossRef]
  82. Stefanetti, R.J.; Voisin, S.; Russell, A.P.; Lamon, S. Recent advances in understanding the role of FOXO3. F1000Research 2018, 7, 1372. [CrossRef]
  83. Cui, C.; Han, S.; Yin, H.; Luo, B.; Shen, X.; Yang, F.; Liu, Z.; Zhu, Q.; Li, D.; Wang, Y. FOXO3 Is Expressed in Ovarian Tissues and Acts as an Apoptosis Initiator in Granulosa Cells of Chickens. BioMed Res. Int. 2019, 2019, 6902906. [CrossRef]
  84. Wang, P.; Geng, J.; Gao, J.; Zhao, H.; Li, J.; Shi, Y.; Yang, B.; Xiao, C.; Linghu, Y.; Sun, X.; et al. Macrophage achieves self-protection against oxidative stress-induced ageing through the Mst-Nrf2 axis. Nat. Commun. 2019, 10, 1–16. [CrossRef]
  85. Peng, S.L. Foxo in the immune system. Oncogene 2008, 27, 2337–2344. [CrossRef] [PubMed]
  86. Cabrera-Ortega, A.; Feinberg, D.; Liang, Y.; Rossa, J.C.; Graves, D.T. The Role of Forkhead Box 1 (FOXO1) in the Immune System: Dendritic Cells, T Cells, B Cells, and Hematopoietic Stem Cells. Crit. Rev. Immunol. 2017, 37, 1–13. [CrossRef]
  87. Bi, Y.; Xu, L.; Qiu, L.; Wang, S.; Liu, X.; Zhang, Y.; Chen, Y.; Xu, Q.; Chang, G.; Chen, G.; et al. Reticuloendotheliosis Virus Inhibits the Immune Response Acting on Lymphocytes from Peripheral Blood of Chicken. Front. Physiol. 2018, 9, 1–9. [CrossRef]
  88. Du, W.W.; Fang, L.; Yang, W.; Wu, N.; Awan, F.M.; Yang, Z.; Yang, B.B. Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity. Cell Death Di er. 2016, 24, 357–370. [CrossRef]
Related topics
Authors:
Hanaa Amin
Follow
Join to be able to comment.
Once you join Engormix, you will be able to participate in all content and forums.
* Required information
Would you like to discuss another topic? Create a new post to engage with experts in the community.
Create a post
Join Engormix and be part of the largest agribusiness social network in the world.
LoginRegister